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Summary 
Heterodimerization is a common paradigm among eu- 
karyotic transcription factors. The 9-cis retinoic acid 
receptor (RXR) serves as a common heterodimeriza- 
tion partner for several nuclear receptors, including 
the thyroid hormone receptor (TSR) and retinoic acid 
receptor @AR). This raises the question as to whether 
these complexes possess dual hormonal respon- 
siveness. We devised a strategy to examine the tran- 
scriptional properties of each receptor individually or 
when tethered to a heterodimeric partner. We find that 
the intrinsic binding properties of RXR are masked in 
T,R-RXR and RAR-RXR heterodimers. In contrast, 
RXR is active as a non-DNA-binding cofactor with the 
NGFI-BINurrl orphan receptors. Heterodimeriration of 
RXR with constitutively active NGFI-B/Nurrl creates 
a novel hormone-dependent complex. These findings 
suggest that allosteric interactions among heterodi- 
mers create complexes with unique properties. We 
suggest that allostery is a critical feature underlying 
the generation of diversity in hormone response net- 
works. 
Introduction 
Heterodimerization is a common theme in eukaryotic regu- 
latory biology. A number of transcription factor families 
have been defined by their characteristic dimerization in- 
terface. These include the leucine zipper (e.g., Fos, Jun, 
CAMP response element-binding protein, and CCAAT en- 
hancer-binding protein) (Lamb and McKnight, 1991), he- 
lix-loop-helix (e.g., Myc, Max, MyoD, E12, and E47) (Amati 
and Land, 1994), Rel (NF-KB and dorsal) (Blank et al., 
1992), ankyrin (GA-binding protein) (Brown and McKnight, 
1992), and the nuclear receptor superfamilies (Evans, 
1988; Forman and Samuels, 1990). Detailed analysis of 
these proteins have shown that heterodimerization pro- 
duces novel complexes that bind DNA with higher affinity 
or altered specificity (Glass, 1994). In contrast, little is 
known about the contributions of each monomer toward 
the transcriptional properties of the complex. Nuclear re- 
ceptor heterodimers provide an ideal system to examine 
these questions since transcriptional responses are regu- 
lated by steroids, retinoids, thyroid hormones, fatty acids, 
and other signaling molecules (Evans, 1988). 
Nuclear hormone receptors are characterized by a cen- 
tral DNA-binding domain (DBD) (Figure 1 A), which targets 
the receptor to specific DNA sequences known as hor- 
mone response elements (HREs). The all-trans retinoic 
acid receptor (RAR), the receptor of the thyroid hormone 
receptor (TsR), the vitamin D3 receptor (VDR), and 
the fatty acidlperoxisome proliferator-activated receptor 
(PPAR) preferentially bind to DNA as heterodimers with 
a common partner, the 9-cis retinoic acid X receptor (RXR) 
(Vu et al., 1991; Bugge et al., 1992; Kliewer et al., 1992a; 
Leid et al., 1992; Marks et al., 1992; Zhang et al., 1992; 
lssemann et al., 1993). Naturally occurring HREs are com- 
posed of direct repeats (DRs) (Umesono et al., 1991), in- 
verted repeats (IRS) (Umesono et al., 1988; Williams et 
al., 1991), or everted repeats (ERs) (Baniahmad et al., 
1990; Farsetti et al., 1992; Raisher et al., 1992; Tini et al., 
1993) of a degenerate X,-AGGTCA core site. The DBD 
contains two helical regions, one of which serves as a 
recognition helix that makes base-specific contacts within 
the major groove of the core site (Luisi et al., 1991; 
Schwabe et al., 1993). A third helix has been identified in 
some receptors that makes additional minor groove con- 
tacts in the 5’ portion of the core-binding site (X.) (Wilson 
et al., 1992; Lee et al., 1993). In DRs (head-to-tail arrange- 
ment), the X, sequence also serves as a gap that separates 
the two core-binding sites. Spacers of 1, 3, 4, and 5 nt 
serve as preferred response elements for heterodimers 
of RXR with PPAR, VDR, T,R, and RAR, respectively 
(Naar et al., 1991; Umesono et al., 1991; Kliewer et al., 
1992b; lssemann et al., 1993). The optimal gap length for 
each heterodimer is determined by protein-protein con- 
tacts that appropriately position the DBDs of RXR and 
its partner (Kurokawa et al., 1993; Perlmann et al., 1993; 
Towerset al., 1993; Predki et al., 1994;Zechelet al., 1994). 
In contrast with this mode of DNA binding, a growing num- 
ber of receptor-like proteins have been identified that bind 
as a monomer to a single core site. The orphan receptors 
of the NGFI-B (also known as nur77, NlO, NAK-1, and 
TR3) and Nurrl (also known as RNR-1, NOT, and HZF3) 
family provide well-characterized examples of this para- 
digm (Wilson et al., 1993). 
Once bound to an HRE, each receptor responds to its 
signal through the C-terminal ligand-binding domain (LBD) 
that binds its cognate hormone with high affinily and speci- 
ficity (Evans, 1988; Forman and Samuel% 1990). The LBD 
is a complex entity containing several embedded subdo- 
mains. These includeac-terminal transactivation function 
(AF-2), a series of heptad repeats that serve as a dimeriza- 
tion interface, and a poorly delineated transcriptional sup- 
pression domain (Figure 1A) (Forman and Samuel% 1990). 
AF-2 resides at the C-terminus (Zenke et al., 1990; Dan- 
ielian et al., 1992; Nagpal et al., 1993; Durand et al., 1994) 
and consists of approximately 20 amino acids with the 
potential to form an amphipathic a helix (Barettino et al., 
1994; Schulman et al., submitted). When linked to a heter- 
ologous DBD, AF-2 displays constitutive transcriptional 
activity (Barettino et al., 1994; Schulman et al., submitted). 
However, in the natural context of the LBD, transcriptional 
activity requires the addition of ligand. This indicates that 
the LBD functions as a modular unit whose transcriptional 
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Figure 1. RXR Responsiveness Is Differentially Modulated by TSR and 
RAR 
(A) Functional domains of nuclear hormone receptors. The location 
of key functional domains in nuclear receptors are shown schemati- 
cally. The box marked DNA represents the DBD. The box marked 
ligand represents the large C-terminal LBD. Dimerization and trans- 
activation (AF-2) functions are embedded within this region. 
(B) Transient transfection analysis of TSR-RXR and RAR-RXR hetero- 
dimers. Reporter constructs contain the indicated HRE cloned up- 
stream of the TK-LUC reporter. In the experiment shown on the left, 
CV-1 cells were transfected with the following plasmids: HRE x 2 TK- 
LUC (300 rig/l Oscells), CMX-hTsR5 (20 ngll Oscells), CMX-hRXRa (20 
ng/105 cells), and the internal control CMX+gal (500 ng/105 cells). 
Cells were treated without ligand or with 100 nM Ts, 100 nM LG69, 
or 100 nM T3 and 100 nM LG69. In the experiment shown on the right, 
cells were transfected with HRE x 1 TK-LUC (300 rig/l 05 cells), CMX- 
hRARa (50 nglIOS cells), CMX-hRXRa (50 ng/105 cells), and CMX- 
B-gal (500 ng/105 cells). Cells were treated without ligand or with 50 
nMAm560,lOOnM LG69,or50nM Am560and 100nM LG69. Normal- 
ized LUC activity was determined and plotted as fold activation relative 
to untreated cells. 
activities are controlled by ligand. Thus, it may be as- 
sumed that both members of a receptor heterodimer will 
be simultaneously activated by their specific ligands. Con- 
trary to this expectation, we now provide evidence that 
the ligand-induced transcriptional activities of RXR are 
suppressed when complexed with RAR and T,R. This sup- 
pression occurs at the levels of ligand binding and tran- 
scriptional activation and can be further modulated by the 
ligand for the partner. Furthermore, RXR responsiveness 
was not observed with other partners, including VDR. 
As part of a search for additional RXR partners, we were 
surprised to find that the RXR LBD can interact produc- 
tively with Nurrl , a member of the nuclear receptor super- 
family that binds DNA as a monomer (Law et al., 1992; 
Scearce et al., 1993). As a result of this interaction, the 
constitutive activity of Nurrl is suppressed, and the com- 
plex becomes 9-cis RA dependent. Thus, an LBD can cre- 
ate a hormone-dependent complex even though it is not 
directly bound to DNA. These unique properties establish 
the Nurrl-RXR complex as a novel response pathway for 
RXR signals. 
Taken together, our findings suggest that heterodimer 
formation imparts allosteric changes upon the LBD of nu- 
clear receptors. These allosteric changes confer transcrip- 
tional activities onto the heterodimer that are distinct from 
those of the component monomers. This arrangement per- 
mits a limited number of regulatory proteins to generate 
a diverse set of transcriptional responses to multiple hor- 
monal signals. 
Results 
RXR Responsiveness Is Diminished in T&RXR 
and RAR-RXR Heterodimers 
Since TSR and RAR function as heterodimers with RXR, 
we sought to examine RXR responsiveness in the context 
of T3R-RXR and RAR-RXR heterodimers. Although cells 
transfected with both TSR0 and RXRa expression vectors 
were responsive to T3, they were surprisingly not respon- 
sive to the RXR-specific ligand LG69 (Figure 1 B) (Boehm 
et al., 1994). Treatment of these cells with both T3 and 
LG69 did not result in further stimulation of the TO re- 
sponse; instead, the response to T3 was somewhat re- 
duced (Figure 1 B) (Hallenbeck et al., 1993; Lehmann et 
al., 1993). Similarly, cells simultaneously transfected with 
RARa and RXRa expression vectors responded to the 
RAR-specific ligand Am560 but remained unresponsive 
to LG69 (Figure 1B). In contrast, treatment with Am560 
and LG69 resulted in increased transcriptional activity 
over that seen with Am560 alone (Figure 1 B). 
Suppression of RXR Activity Is Mediated 
by the LSD 
Since RXR homodimers are activated by RXR selective 
agonists (Mangelsdorf et al., 1991; Lehmann et al., 1992) 
our results suggest that RXR activity is suppressed in unli- 
ganded TaR-RXR and RAR-RXR heterodimers. We spec- 
ulated that heterodimerization within the LBD (Figure 1A) 
could induce an allosteric change in the RXR LBD that 
blocks its ability to bind ligand, to transactivate, or both. To 
test this hypothesis, we developed a system that examines 
the responsiveness of RXR-containing heterodimers in a 
manner that relies solely on interactions between the LBDs. 
A chimeric protein was constructed containing the yeast 
GAL4 DBD linked to the RXR LBD (GAL-RXR). The ability 
of this RXR chimera to respond to LG69 was initially exam- 
ined in the presence of truncated receptors containing the 
LBDs of T,R or RAR. Although GAL-RXR activated the 
upstream activating sequence (UASG) reporter in response 
to LG69, the absolute levels of induced and uninduced 
activity were dramatically suppressed by both T,R and 
RAR LBDs (Figure 2A). In contrast, the VDR LBD failed 
to suppress RXR responsiveness. These results indicate 
that suppression of RXR by unliganded T3R and RAR is 
mediated solely by interactions between the LBDs of these 
receptors. 
Our results are consistent with previous experiments 
that have shown that receptor LBDs remain tethered to 
the GAL-RXR LBD in cells (Nagpal et al., 1993). Thus, 
we asked whether the tethered LBDs can activate tran- 
scription in response to their specific ligands. As seen 
in Figure 2A, the T3R, RAR, and VDR LBDs conferred 
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Figure 2. Transcriptional Activity of RXR is Differentially Modulated 
by the LBDs of TIR and RAR 
(A) Transient transfection analysis of GAL-RXR LBD in the presence 
of TJR, RAR, or VDR LBDs. Reporter constructs contained four copies 
of the UASe cloned upstream of the TK-LUC reporter. CV-1 cells were 
transfected with UASG x 4 TK-LUC (300 ng/105 cells), CMX-GAL- 
RXR (100 ng/105 cells), or CMX-8-gal (500 ng/105 cells) alone or with 
either CMX-T,R LBD, CMX-RAR LBD, or CMX-VDR LBD (100 ngl 
105 cells). Following transfection, cells were treated without ligand or 
with 100 nM LG69,lOO nM TI, 50 nM Am580, or 100 nM VD,. Normal- 
ized LUC activity was determined and plotted as reporter activity. 
(8) The cells in (A) were additionally treated with 100 nM TB and 100 
nM LG69 (left) or 50 nM Am580 and 100 nM LG69 (right). Normalized 
LUC activity was determined and plotted as fold activation relative to 
untreated cells. 
ligand-dependent activation upon GAL-RXR, but not on 
GAL4 alone (data not shown). Thus, receptor LBDs teth- 
ered to RXR provide all the functions required for ligand- 
dependent transcriptional activation in the absence of di- 
rect DNA contact. 
The experiment of Figure 2A was also performed with 
the combination of RXR-specific (LG69) and TSR- or RAR- 
specific ligands (Figure 28). To compare the effects of TaR 
and RAR LBDs on LG69 inducibility of GAL-RXR, these 
data were replotted as fold induction. Comparison of Fig- 
ures 1 B and 2B indicates that the effects of ligand-occu- 
pied TzR and RAR are qualitatively similar whether the 
full-length receptors or their LBDs are used. Note that the 
T3R LBD led to a coordinate reduction in both basal and 
LG69-induced activities of GAL-RXR (Figure 2A); hence, 
Figure 3. T,R and RAR Suppress Transcription of a Constitutively 
Active RXR Derivative 
In the experiment shown on the left, CV-1 cells were transfected with 
the following plasmids: with IRO TK-LUC (300 ngllo5 cells) or CMX- 
p-gal (500 ng/105 cells) alone (minus) or with CMX-VPIG-RXRa (100 
ng/lOs cells), CMX-hT3R6 (50 ng/lOs cells), or both, as indicated. In 
a separate experiment, shown on the right, cells were transfected with 
IRO TK-LUC (300 ng/105 cells) or CMX+gal(500 ng/105 cells) alone 
(minus)orwithCMX-VP16-RXRa(100 ng/ltYcells), CMX-hRARa(50 
ng/105cells), or both, as indicated. No ligand treatment wasemployed. 
LUC activity was normalized to the B-gal internal control. In each exper- 
iment, the normalized activity obtained in the presence of VP1 6-RXR, 
TSR, or RAR is plotted as activity relative to the reporter alone, which 
was defined to have a relative activity of 1. 
the fold response to LG69 was only modestly inhibited 
from 69-fold (GAL-RXR alone; Figure 28, left) to 57-fold 
by the T,R LBD (GAL-RXR and T,R LBD; Figure 28, left). 
Addition of T3 resulted in strong activation of TSR, and the 
combination of T3 and LG69 resulted in slightly less activity 
than with T3 alone. In contrast with T3R, unliganded RAR 
LBD strongly suppressed the fold responsiveness of GAL- 
RXR to LG69. Treatment with Am560 and LG69 resulted 
in increased transcriptional activity over that seen with 
Am560 alone, suggesting that RXR responsiveness to 
LG69 may be partially restored by addition of the RAR 
agonist Am560 (Figure 28). 
T3R and RAR Suppress Activation of 
RXR-Containing Heterodimers 
Taken together, our results indicate that T,R and RAR act 
in trans to suppress the absolute transcriptional activity 
of RXR. Ligand-free RAR additionally suppresses the abil- 
ity of RXR to activate in response to its ligand. In contrast, 
ligand-free TSR only modestly suppresses RXR inducibil- 
ity; full suppression requires the addition of T3R ligands, 
suggesting that ligand binding by one partner can affect 
the activity of the other. 
When bound to DNA, unliganded T3R and RAR are 
known to suppress basal transcription (Damm et al., 1989; 
Baniahmad et al., 1992). This is thought to occur by direct 
interaction of the LBD with the basal transcription factor 
TFIIB (Baniahmad et al., 1993; Fondell et al., 1993). We 
speculated that, in addition to basal suppression, TSR and 
RAR may also interfere with TFIIB-dependent activation. 
To test this idea, we fused the potent herpes VP16 trans- 
activation domain to the N-terminus of RXR (VP16RXR). 
As expected from previous studies (Underhill et al., 1994) 
VP16 confers ligand-independent activity onto the VP1 6- 
RXR chimera (Figure 3). Since VP16 activates transcrip- 
tion by recruiting TFIIB into the preinitiation complex (Rob- 
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erts and Green, 1994) the constitutive activity of VP1 6-RXR 
is presumed to represent TFIIB-dependent activation. In 
cotransfection experiments, unliganded TJt and RAR in- 
hibited VPlG-RXR activation of the IRO reporter (Figure 
3). Suppression was observed on other RXR response ele- 
ments, including cellular retinal-binding protein II (CRBPII) 
(DRl) and an ER separated by 8 nt (data not shown), indi- 
cating that suppression occurs independent of specific 
HRE architecture. These data indicate that unliganded 
T3R and RAR suppress TFIIB-dependent activation when 
complexed with RXR. 
RAR and T3R Differentially Suppress the 
Ligand-Binding Activity of RXR 
In addition to decreasing basal and activated transcription, 
RAR also blocked the ability of RXR to respond to its ligand 
(see Figure 28). Thus, we examined the possibility that 
RXR was incapable of binding ligand when tethered to 
RAR. A bacterially expressed glutathione S-transferase- 
RXRa fusion protein (GST-RXR) was incubated with re- 
combinant T,R or RAR in the presence of radiolabeled 
RXR ligands. The amount of ligand bound to RXR or RXR- 
containing heterodimers was quantitated using glutathi- 
one-Sepharose as an affinity probe. As expected, binding 
of [“H]LG69 to GST-RXR was specifically competed by 
unlabeled LG69, but not by the RAR-specific ligand Am580 
(Figure 4A, left). Conversely, GST-RXR was incapable 
of binding to [3H]all-frans RA (Figure 4A, right); specific 
binding of [3H]all-frans RA was observed when GST-RXR 
was mixed with excess RAR (Figure 4A, right). A quantita- 
tion of the amount of specifically bound 13H]LG69, [3HJall- 
trans RA, or [1251]T3 (data not shown) indicated that GST- 
RXR could be saturated with approximately equimolar 
amounts of RAR or T$l, respectively (see legend to Figure 
4; data not shown). Electrophoretic mobility shift experi- 
ments indicated that ligands did not alter the binding activ- 
ity of T,R-RXR or RAR-RXR heterodimers (data not 
shown). 
Next, we examined the ligand-binding activity of RXR 
in the presence of RAR or T,R. Surprisingly, addition of 
FlAR resulted in a dramatic (>85%) decrease in the amount 
of [3H]LG69 bound to GST-RXR (Figure 4B), indicating 
that the ligand binding potential of RXR is reduced in the 
RAR-RXR heterodimer. These findings account for the 
ability of unoccupied RAR to suppress the ligand inducibil- 
ity of RXR (see Figure 28, right). 
Similar experiments were performed on the TSR-RXR 
heterodimer. In contrast with RAR, unliganded T3R led to 
a modest reduction in PH]LG69 binding. However, ligand 
binding was strongly diminished upon addition of TJ (Fig- 
ure 48). These findings are consistent with the observation 
that unoccupied TsR results in a modest suppression of 
RXR inducibility, whereas no further induction is elicited 
when TSR is occupied by TS (see Figure 28, left). 
The transfection experiments in Figures 1 B and 28 indi- 
cate that RAR-RXR heterodimers exhibit RXR respon- 
siveness only in the presence of an RAR ligand, sug- 
gesting that RXR-binding activity may be restored by RAR 
ligands. To test this hypothesis, we made use of the obser- 
vation that 9-cis RA binds with high affinity to both RAR 
A 
Figure 4. The Ligand-Binding Activity of RXR Is Altered by T,R and 
RAR 
(A) Binding of LG69 and all-trans RA to RXR and RAR. In the experi- 
ment shown on the left, purified GST-hRXRa was incubated with 50 
nM (Yf]LG69 (56 Cilmmol) and the optimized RAR response element 
5’-GCAAAAGGTCAAAAAGAGGTCATGC-3’ (Kurokawa et al., 1993) 
alone or with 2 uM LG69 and 2 pM Am580. In the experiment shown 
on the right, purified GST-hRXRa and the RAR response element 
were incubated with 25 nM [3H]all-trans RA (49 Cilmmol) without or 
with 500 ng of hRARa. The amount of specifically bound [“H] was then 
determined as described in Experimental Procedures. 
(B) Binding of LG69 to RXR is reduced in RAR-RXR and T,R-RXR 
heterodimers. Purified GST-hRXRa and 50 nM PH]LG69 (56 Cilmmol) 
were incubated alone or with 500 ng of hRARa or chicken T3Ral and 
the optimized RAR response element or the optimized TsR response 
element 5’-GCAAAAGGTCAAATAAGGTCACGT-3’ (Kurokawa et al., 
1993) respectively. Where indicated, unlabeled T3 was added to a 
concentration of 1 uM. Specifically bound [3H]LG69 was determined. 
(C) Competition of [“HIS& RA bound to RAR-RXR heterodimers re- 
quires RAR and RXA ligands. Reactions were performed as in (A) 
using both GST-hRXRa and hRARa with 50 nM PH]9-cis RA (29 Gil 
mmol). Specifically bound [3H]9-cis RA was determined in the absence 
or presence of 2 uM LG69, 2 uM Am580, or both. In all experiments, 
maximal binding was in the range of 200-300 fmol of 3H-labeled ligand. 
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Figure 5. A Novel Nurrl-RXR Complex Pro- 
vides a Signaling Pathway for 9-cis RA 
CV-1 cells were transfected with TK-LUC re- 
porters (306 ng/lQ cells), CMX+gal(500 ng/ 
106 cells), and the indicated CMX-receptor 
construct (20 ng/lOS cells) with or without 
CMX-RXR LED (100 rig/l 05 cells). The follow- 
ing receptor, reporter, and ligand combinations 
were used: Nurrl, NBRE x 3, 100 nM LG69; 
hT3R6, MLV x 2,100 nM T3; hRARa, DR5 x 
2.100 nM Am660; hVDR, SPPI x 3,100 nM 
VDI. Normalized LUC activity was determined 
and plotted as percent of maximal fold activa- 
tion where 100% is defined as the fold activa- 
tion by Nurrl and RXR LBD or by TSR, RAR, 
and VDR in the absence of RXR LBD. The ac- 
tual fold activation values are shown above 
each bar. 
(A) Transient transfection analysis of GAL- 
receptor LBD chimeras in the presence of the 
RXR LBD. CV-1 cells were transfected with 
UA& x 4 TK-LUC (300 @IO5 cells), CMX- 
B-gal (500 ng/lO’ cells), and the indicated 
CMX-GAL-receptor LBD construct (100 ng/ 
105 cells) with or without CMX-RXR LBD (106 
q/105 cells). Following transfection, cells were 
treated without or with ligand 100 nM LG69. 
Normalized LUC activity was determined and 
plotted as fold activation relative to untreated 
cells. 
(B) Transient transfection analysis of full-length Nurrl and RXR. CV-1 cells were transfected with NBRE x 3 TK-LUC (300 ng1105 cells), CMX- 
p-gal (500 ng/lOs cells), alone or with CMX-Nurrl (100 ng/lO’ cells) and CMX-hRXRa (100 @IO5 cells) as indicated. Following transfoction, cells 
were treated with or without 100 nM LG69. Normalized LUC activity was determined and plotted as reporter activity. 
(C) Comparison of Nurrl-RXR with RXR. Cells were transfected as in (6) but with a C-fold lower amount of CMX-hRXRa (20 ng/lOS cells). CRBPII 
TK-LUC (300 ng1105 cells) was used as indicated. 
(D) RXR LBD activates through Nurrl but inhibits activation of other receptors. 
and RXR (Allegretto et al., 1993; Allenby et al., 1993). 
Thus, GST-RXR and GST-RAR heterodimers were al- 
lowed to form in the presence of [3H]9-cis RA. Although 
Am580 fully competed with rH]all-trans RA for binding to 
GST-RXR and GST-RAR heterodimers (Figure 4A, right), 
Am580 resulted in only a partial decrease in [3H]9-cis RA 
binding (Figure 4C). Nearly complete competition was ob- 
served by addition of both Am580 and the RXR-specific 
ligand LG69 (Figure 4C), suggesting that RXR can bind 
ligand provided that the RAR LBD is occupied. These find- 
ings are consistent with the restoration of RXR respon- 
siveness in RAR-occupied heterodimers (see Figure 28, 
right). 
identification of a Novel 
RXR-Permissive Heterodimer 
Since RXR served as a silent partner in the T,R and RAR 
pathways, we wondered whether RXR could serve as an 
active component in other complexes. To search for such 
complexes, we fused the LBD of a number of nuclear re- 
ceptors to the GAL4 DBD and asked whether the RXR 
LBD could confer LG89 responsiveness upon these GAL- 
LBD chimeras. As expected, LG69 responsiveness was 
not seen when the RXR LBD was expressed alone (data 
not shown) or with GAL-TsR and GAL-RAR (Figure 5A). 
Similarly, LG69 inducibility was not observed with chime- 
ras containing the LBDs of VDR (Figure 5A) or several 
other members of the nuclear receptor superfamily (data 
not shown). Unexpectedly, strong responsiveness to 
LG69 was observed when the RXR LBD was coexpressed 
with a GAL-Nurrl chimera (Figure 5A). These results sug- 
gest that the LBDs of Nurrl and RXR form a complex that 
is responsive to RXR agonists. 
Nurrl , the 8 isoform of NGFI-B, is reported to be a consti- 
tutively active orphan receptor that binds as a high affinity 
monomer to an AAAGGTCA core site, the NGFI-B re- 
sponse element (NBRE) (Law et al., 1992; Wilson et al., 
1992, 1993; Scearce et al., 1993). This prompted us to 
ask whether full-length Nurrl and RXR could interact pro- 
ductively on the NBRE. Consistent with published results 
(Scearce et al., 1993) Nurrl alone constitutively activates 
the NBRE reporter (Figure 58) and is not responsive to 
LG69 (Figure 58). RXR, which does not bind to the NBRE 
(data not shown), did not activate this reporter. However, 
when Nurrl and RXR are coexpressed, the constitutive 
activity of Nurrl is suppressed, and the complex becomes 
strongly responsive to LG69 (Figure 58). LG69 and 9-cis 
RA responsiveness was also observed with the 6 and y 
isoforms of RXR and when NGFI-B was used in place 
of Nurrl (data not shown). The ability of Nurrl-RXR to 
transduce RXR signals led us to compare the activity of 
this complex with that of RXR on an established RXR re- 
sponseelement (CRBPII)(Mangelsdorfet al., 1991). Using 
suboptimal amounts of an RXR expression vector, we 
compared the CRBPII reporter with a three-copy NBRE 
reporter. Since RXR was limiting in this assay, we ob- 
served only minimal activation of the CRBPII reporter (Fig- 
ure 5C). In contrast, Nurrl-RXR displayed a potent re- 
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sponse to LG69, despite the fact that the NBRE reporter 
contains one fewer core-binding site than CRBPII (Figure 
5C). Thus, Nurrl-RXR can efficiently transduce RXR sig- 
nals supporting the physiologic relevance of this complex. 
The Nurrl-RXR complex establishes a novel signaling 
pathway for 9-cis RA as well as a novel role of RXR in 
hormonal signaling. 
Nurrl Does Not Require the RXR DBD for Coupling 
The Nurrl-RXR complex is unique in several ways. First, 
the Nurrl DBD recognizes its response element in the 
absence of RXR (Wilson et al., 1992, 1993; Scearce et 
al., 1993). Second, the monovalent NBRE serves as a 
response element for a multimeric Nurrl-RXR complex 
(Figure 58). These observations raise the possibility that 
RXR associates with NBRE-bound Nurrl in the absence 
of RXR-specific DNA contacts. Such behavior would be 
in sharp contrast with T3R, RAR, and VDR, which rely on 
RXR-specific contacts to recognize HREs. Indeed, RXR 
mutants lacking the DBD associate with wild-type RAR; 
however, these complexes do not bind DNA or activate 
transcription (Minucci et al., 1994). This prompted us to 
ask whether the RXR LBD was sufficient for activation 
through the Nurrl pathway. Indeed, as shown in Figure 
5D, the RXR LBD confers strong LG69 responsiveness 
upon coexpressed Nurrl. In contrast, the RXR LBD acts 
as a dominant negative inhibitor of wild-type TSR, RAR, 
and VDR because these complexes require two DBDs to 
bind DNA (Figure 5D). These findings indicate that the 
RXR DBD is not required for ligand-dependent activation 
of Nurrl-RXR, a property that further distinguishes this 
complex from previously described RXR-containing com- 
plexes. Although the monovalent NBRE serves as an HRE 
for Nurrl-RXR heterodimers, it remains possiblethat biva- 
lent HREs may also exist for this complex (T. Perlmann, 
personal communication). 
Discussion 
The LBD of nuclear hormone receptors is a complex multi- 
functional unit containing subdomains for dimerization, 
transcriptional suppression, and hormone-induced trans- 
activation (Forman and Samuels, 1990). The dimerization 
domain includes a series of heptad repeats flanked by 
sequences required for ligand binding (Forman and Sam- 
uels, 1990). Thus, the dimerization domain is embedded 
within the larger LBD. This structural arrangement raises 
the possibility that dimerization may serve as an allosteric 
modulator of ligand binding and transactivation. We have 
addressed this issue and established the following points. 
Dimerization Modulates Ligand Binding 
and Transactivation 
First, dimerization within the LBD is utilized to confer tran- 
scriptional suppression upon a heterodimeric complex. 
This is exemplified by unliganded T3R and RAR, which 
confer transcriptional suppression- upon RXR. Recipro- 
cally, we have shown that RXR can suppress constitutive 
activation by Nurrl. 
Second, the intrinsic ligand binding capacity of the LBD 
can be modulated by dimerization. This is highlighted by 
the ability of unliganded RAR to abrogate the ligand- 
binding activity of RXR (Figure 4; Kurokawa et al., 1994). 
We also find that T$I suppresses RXR ligand binding but 
requires T3 for the complete effect. Thus, RXR serves as 
a silent partner in the T,R and RAR pathways. However, 
not all heterodimeric interactions restrict ligand respon- 
siveness. We show that RXR actively confers ligand re- 
sponsiveness upon the novel Nurrl-RXR complex, and 
we have previously shown that the Drosophila ecdysone 
receptor (EcR) acquires ligand-binding activity after hetere 
dimerization with oltraspiracle (Drosophila homolog of 
RXR) (Yao et al., 1993). Thus, differential interactions 
among receptor LBDs can either restrict, redirect, or lead 
to an acquisition of ligand-binding phenotypes. 
Allosteric Control: A Structural Model 
We propose the following structural model (Figure 6; 
Forman and Samuels, 1990) to account for our findings. 
In this model the RXR monomer (or homodimer) is capable 
of binding ligand with high affinity. When RXR interacts 
with one of its nonpermissive partners (T3R or RAR), its 
ability to bind ligand is diminished. On the other hand, 
dimerization of u/traspirac/e/RXR with EcR promotes high 
affinity binding of ecdysone to EcR. We hypothesize that 
these effects are a direct consequence of the localization 
of a major dimerization interface within the LBD (Figures 
1A and 6). Our model predicts that this structural arrange- 
ment serves functionally to link dimerization and ligand- 
binding activities. This provides a mechanism fordimeriza- 
tion to exert allosteric control over the ligand response. 
In addition to dimerization, ligand binding may result in 
a second allosteric modification of the partner receptor. 
Thus, binding of ligand to RAR restores the RXR response; 
in the case of TaR, the addition of Tg further suppresses 
the response (Figure 4). This has the consequence of mak- 
ing the RAR complex uniquely responsive to retinoids 
while the TSR complex is only responsive to T3. It is already 
known that upon ligand binding, the cognate receptor un- 
dergoes a conformation change (Toney et al., 1993). Our 
data lead to the prediction that ligand-induced conforma- 
tion changes in the LBD of one heterodimer partner will 
be propagated through the dimerization interface onto the 
LBD of the partner. This model can explain how the dimer- 
ization partner and its specific ligand exert allosteric con- 
trol over the RXR ligand response. This same model can 
account for the ability of ligand to either promote EcR- 
ukraspiracle (Yao et al., 1993) or destabilize VDR-RXR 
(MacDonald et al., 1993; Cheskis and Freedman, 1994) 
and T3R-T3R (Andersson et al., 1992; Ribeiro et al., 1992; 
Yen et al., 1992) dimers. 
Physiologic Implications 
The restriction of RXR activity within certain heterodimers 
indicates that 9-cis RA responsiveness is not an obligatory 
consequence of heterodimerization with RXR. This allows 
RXR to be both a receptor and heterodimerization partner 
without requiring all target genes to be 9-cis RA respon- 
sive. This explains the paradox as to how RXR serves as 
a common subunit for receptors that display independent 
Allosteric Control of Nuclear Hormone Receptors 
547 
1 LBD 
I 
DBD 
Figure 6. The Allosteric Control Model of Ligand Responsiveness 
RXR (dark stippling) and its partner receptor T,R, RAR, or Nurrl (R; 
light stippling) initially exist as monomers in solution. The RXR mono- 
mer is capable of binding ligand. Receptor-RXR heterodimers then 
form, driven by the dimerization interface that is embedded within 
the LED. Subsequent to dimerization, binding of 9-cis RA to RXR is 
modestly reduced by T,R and dramatically reduced by RAR. Addition 
of Ta results in a further reduction in S-cis RA binding, while certain 
RAs such as Am580 may restore 9-cis RA binding to RAR-RXR. The 
Nurrl-RXR heterodimer maintains the ability to bind 9-cis RA. Our 
structural model relies on the observation that a major dimerization 
interface is embedded within the larger LBD. We propose that upon 
dimerization, the structure of the RXR LBDldimerization domain is 
altered. Each RXR partner gives rise to unique conformation changes 
that either maintain or abrogate RXR ligand-binding activity. Binding 
of ligand by the partner receptor induces a conformation change that 
can be propagated through the dimerization interface onto the LBD 
of RXR. This model can explain how the dimerization partner and its 
specific ligand exert allosteric control over the RXR ligand response. 
physiologic effects (e.g., T3R, RAR, and VDR). We have 
not explored the mechanisms by which RXR respon- 
siveness is abolished in VDR-RXR heterodimers. This 
may be related to the observation that 9-cis RA can bind 
to and destabilize VDR-RXR heterodimers (MacDonald 
et al., 1993; Cheskis and Freedman, 1994). 
In contrast, the ability of RXR to transduce signals when 
complexed with NGFI-B or Nurrl suggests an alternative 
pathway for 9-cis RAsignaling, This pathway may regulate 
the physiology of cells that coexpress RXR and NGFI-BI 
Nurrl. RXR is found throughout the body with one or more 
isoforms expressed in virtually all cells and tissues (Man- 
gelsdorf et al., 1992; Titcomb et al., 1994). NGFI-B is ex- 
pressed in a variety of unstimulated tissues, including the 
brain, heart, ovary, muscle, and testis (Ryseck et al., 1989; 
Law et al., 1992), while Nurrl expression is restricted to 
the brain (Law et al., 1992; Scearce et al., 1993). Moreover, 
the expression of both proteins is induced by a number 
of physiological stimuli (Davis and Lau, 1994), including 
membrane depolarization, T cell apoptosis (Liu et al., 
1994; Woronicz et al., 1994), and liver regeneration 
(Scearce et al., 1993). We suggest that RXR may contrib- 
ute to the regulation of these events by functioning as a 
hormone-dependent cofactor. 
The ability of RXR to function as a DNA-dependent pro- 
tein in one context and a cofactor in another is unique 
to enhancer-binding proteins. However, this phenomenon 
has precedence in the TATA-binding protein that partici- 
pates as a cofactor in RNA polymerase I and Ill transcrip- 
tion complexes but binds DNA in the RNA polymerase II 
complex (Pugh and Tjian, 1991; Comai et al., 1992; Cor- 
mack and Struhl, 1992; Meyers and Sharp, 1993; Good- 
rich and Tjian, 1994; Struhl, 1994). An important general 
conclusion is that heterodimerization is a remarkably ef- 
fective means to generate diversity of hormone signaling. 
A more specific conclusion, no less important, is the cen- 
tral role of RXR in this process. 
ExperImental Procedures 
Cell Culture and Transfectlon 
CV-1 cells were grown in Dulbecco’s modified Eagle’s medium supple- 
mented with 10% resin-charcoal-stripped (Samuels et al., 1979) fetal 
bovine serum, 50 U/ml penicillin G, and 50 pglml streptomycin sulfate 
(DMEM-FBS) at 37OC in 5% COr. Cells were plated to 50%-80% 
confluence 1 day prior to transfection, using phenol-red free DMEM- 
FBS. Cells were transfected by lipofection using N-[Z-(2,3)-dioleoy- 
loxy)propyl-N,N,N-trimethyl ammonium methyl sulfate) (DOTAP) ac- 
cording to the instructions of the manufacturer (Boehringer Mannheim). 
After 2 hr, the liposomes were removed and cells treated for 40 hr 
with phenol-red free DMEM-FBS alone or with the following ligands: 
100-300 nM Ta (L-triiodothyronine), 100 nM LG69 @[I-(3,5,5,8,6- 
pentamethyl-5,6,7,8-tetrahydro-2-napthyl)-l~~henyl ]benzoic acid), 
50-100 nM Am580 (4-(5,6,7,8-telrahydro-5,5,8,8-tetramethyl-2-napth- 
amido)benzoic acid), or 100 nM VDJ (1 a,25-dihydroxyvitamin D3). Cells 
were harvested and assayed for luciferase (LUC) and 8-galactosidase 
(P-gal) activity. All points were performed in triplicate in each experi- 
ment and varied by less than 10%. Each experiment was repeated 
three or more times with similar results. 
Expression and Reporter Constructs 
For LUC assays, response elements with Hindlll overhangs were 
cloned into the Hindlll site of the thymidine kinase (TK)-LUC reporter 
that contains the herpes virus TK promoter (-105/+51). Response 
elements with the underlined consensus hexanucleotide sequence 
were as follows: UASG x 4 (5’-CGACGGAGTACTGTCCTCCGAGCT; 
four copies); IRO = TREp (5’-TCAGGTCA TGACCTGAG; one and two -- 
copies); DR4 x 2 (5’-AAAGGTCACGAAAGGTCACCATCCCGG- - - 
GAAAAGGTCACGAAAGGTCACC); DR5 (S’CAGGTCACCAGGAGG- - - 
-GAG); DR5 x 2 (5’~AAAGGTCACCGAAAGGTCACCATCCCG- 
GGAAAAGGTCACCGAAAGGTCACC); ER8 (5’-TGACCTTTCTCTC- 
CAGGTCA); NBRE x 3 (5’-GAGTmAAAAGGTCATGCTCAAT- 
llTC; three copies); CRBPII (5’-GTCACAGGTCACAGGTCACAGGT- 
CACAGlTCA); MLV-DR4 x 2 (5’CAGmmmCClTG; - - 
two copies); SPPl/osteopontin-DR3 x 3 (5’~AAGGlTCACGAGGTT- - - 
MCGT; three copies). All mammalian expression vectors were de- 
rived from pCMX (Umesono et al., 1991), which contains the CMV 
promoter/enhancer followed by a bacteriophage T7 promoter for tran- 
scription in vitro. pCMX expression vectors for T,RP, human RARa 
(hRARa), (Umesono et al., 1991), and human RXRa (hRXRa) (Yao 
et al., 1993) were previously described. CMX-Nurrl (provided by T. 
Perlmann), an expression vector for full-length mouse Nurrl, was 
cloned by inserting the Bglll-Xhol fragment from pBS34-1 (excised 
from W4P34) (Law et al., 1992) into pCMX. The VPlG-RXR fusion 
contains the 78 amino acid transactiva6on domain of herpes VP16 
from pVP16Cl (Novagen)fused N-terminal to full-length hRXRa. GAL4 
fusions were made by fusing the following receptor LBDs to the 
C-terminal end of the yeast GAL4 DBD (amino acids l-147) from 
pSG424 (Sadowski and Ptashne, 1989): hRXRa LBD (Glu-203-Thr- 
462); mouse Nurrl (Cys-318-Phe-598); human TJR13 (hT,R@ (Leu- 
Cdl 
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173-Asp-456); hRARa (Glu-156-Pro-462); and human VDR (hVDR) 
(Glu-92-Ser-427). The LBD expression constructs contain lhe SV40 
tag nuclear localization signal (APKKKRKVG) fused upstream of the 
hT3R6 LBD (Leu-173-Asp-456). the hRARa LBD (Glu-156Pre-462) 
or the hRXRa LBD (Glu-203-Thr-462). CMX+gal contains the Esche- 
richia coli @gal coding sequences derived from pCHl10 (Pharmacia) 
cloned into pCMX. 
Ligand Binding Assays 
Bacterially expressed proteins were used for ligand binding assays 
GST-hRXRa (Mangelsdorf et al., 1991) chicken T,Ral (Forman et al., 
1992) and hRARa (Forman et al., 1992) were expressed and purified to 
near homogeneity as previously described. GST-RXR (150 ng) or a 
GST control (150 ng) were incubated with or without approximately 
500 ng of T&t or RAR in the presence of 50 nM JH-labeled ligands 
(LG69, 56 Cilmmol; all-trens RA, 49 Cilmmol; 9cis RA, 29 Cilmmol), 
3 ng/ul poly(dl.dC), 50 fmollfrl of the indicated oligonucleotide, and 
10 ul of 50% (v/v) epoxy-linked glutathione-Sepharose (Sigma) in li- 
gand-binding buffer (25 mM Tris [pH 7.6],0.5% CHAPS, 100 mM KCI, 
6% glycerol, 1 mM DTT). Where indicated, unlabeled ligands were 
added as follows: LG69.2 PM; Am560,2 pM; TS, 1 uM. The reaction 
was mixed for 30 min at 25OC and then chilled to 4OC for IO min. The 
glutathione-Sepharose beads were washed three times in ligand- 
binding buffer, and the amount of [“H] bound was determined in a 
liquid scintillation counter. Background binding was determined with 
the GST control and represented 3%-5% of the total binding seen 
with GST-RXR 
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